TOP TIERMARKET NEWSWIRE
SEC Form 4 history

MADRIGAL PHARMACEUTI (MDGL) insider trades

MADRIGAL PHARMACEUTI (MDGL) insider trading activity (SEC Form 4). Over the trailing 90 days, MDGL insiders filed 1 purchases totalling $35.0M and 3 sales totalling $7.0M — net BUYING of $28.0M. Most recent filing: Nov 6, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
1
$35.0M
Sells (90d)
3
$7.0M
Net (90d)
+$28.0M
net buying
Most recent
Nov 6, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Nov 6, 2026Kelley Shannon TGCS Sale—$400.00$431Kfiling
Nov 6, 2026Baker Bros. Advisors LPDirP Purchase—$381.49$35.0Mfiling
Sep 11, 2026Sibold William JohnPres, CEOS Sale—$538.65$6.2Mfiling
Aug 20, 2026Kelley Shannon TGCS Sale—$514.97$342Kfiling
Jul 20, 2026Sibold William JohnPres, CEOS SaleOE—$547.30$1.4Mfiling
Jun 1, 2026Soergel DavidChief Medical OfficerS Sale—$495.74$517Kfiling
May 22, 2026Levy Richard SDirS Sale—$515.44$2.9Mfiling
May 18, 2026Soergel DavidChief Medical OfficerS Sale—$515.90$435Kfiling